Package 69339-186-03

Brand: risperidone

Generic: risperidone
NDC Package

Package Facts

Identity

Package NDC 69339-186-03
Digits Only 6933918603
Product NDC 69339-186
Product ID 69339-186_856d65dc-f330-4195-b271-d0bdbe99519d
Description

30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-186-03)

Marketing

Marketing Status
Marketed Since 2023-10-14
Brand risperidone
Generic risperidone
Sample Package No

Linked Drug Pages (1)

Risperidone ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "856d65dc-f330-4195-b271-d0bdbe99519d", "openfda": {"nui": ["N0000175430"], "unii": ["L6UH7ZF8HC"], "rxcui": ["401953", "401954", "403825", "616698", "616705", "645037"], "spl_set_id": ["856d65dc-f330-4195-b271-d0bdbe99519d"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Natco Pharma USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-186-03)", "package_ndc": "69339-186-03", "marketing_start_date": "20231014"}], "brand_name": "Risperidone", "product_id": "69339-186_856d65dc-f330-4195-b271-d0bdbe99519d", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "69339-186", "generic_name": "Risperidone", "labeler_name": "Natco Pharma USA LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Risperidone", "active_ingredients": [{"name": "RISPERIDONE", "strength": "4 mg/1"}], "application_number": "ANDA091537", "marketing_category": "ANDA", "marketing_start_date": "20231014", "listing_expiration_date": "20261231"}